Company
Croda International PLC
LON:CRDA
Croda International is a United Kingdom-based manufacturer of speciality chemicals. The Company has manufacturing facilities in 13 countries across Europe, the Americas and Asia.
126 stories · page 2 of 7
Archive
FTSE 100 ends choppy trading week in the red
The FTSE 100 closed out a choppy trading week on the wrong side of the 7,600 level
Croda gets US$75mln from US government to expand lipid systems manufacturing
The company expects the market for lipid systems “to grow significantly over the next 10 years”
Archive
FTSE 100 ends higher lifted by China rate cut and UK retail sales data
A surprise interest rate cut in China appears to have lifted global market sentiment
Potash, fish and Croda among the winners from food inflation, says Credit Suisse
Food prices tend to stay higher for longer during times of inflation
Croda's polar lipids more valuable than gold, suggests broker
“Polar lipids are used to make the lipid nanoparticles that encapsulate and transport the RNA in the COVID-19 vaccines"
Croda upgraded by UBS as it 'ticks all the boxes' with Pfizer contract and likely disposals
Disposal of 75% of the combined PTIC divisions seems “most likely”, which would leave the chemicals group in a net cash positive position by the end of 2022
Croda could see opportunity in mRNA vaccine growth, says broker
Analysts at Berenberg flagged up the firm's sales of lipids used in COVID-19 mRNA vaccines as well as comments from BioNTech co-founder Ugur Sahin that “a third of all newly approved medications could be based on mRNA in 15 years’ time”
Croda raises guidance as COVID vaccine-related sales soar
Croda is now working on more than 100 COVID-19 projects in 20 countries across its three patient health platforms and expects lipid systems sales to top US$200mln this year.
Croda: Could the Pfizer jab provide a shot in the arm for the speciality chemicals group? This leading London bank thinks so
A 17-page circular from HSBC said: “We detect that Croda is changing."
Croda double-upgraded by Goldman Sachs on cosmetics comback and new mRNA opportunities
The comeback for consumer care after several lacklustre years is expected to be driven by “a rebound in volumes, raw material inflation, M&A and the strong long-term outlook for key customers”
Archive
FTSE 100 closes a shade lower on quiet news day
The UK's top share index finished a shade down at 7,026, off by nearly three points, or 0.04%
Croda mulls sale of performance technologies & industrial chemicals businesses
The chemicals firm is focusing on the consumer care and life sciences sectors
Archive
FTSE 100 closes higher as US data cheers
The UK's index of leading shares finished ahead by over 116 points, or 1.68%, at 7,039
Croda upped to buy by Citi following Iberchem acquisition
The bank said the acquisition of the Spanish firm offered Croda “access to the fastest-growing regions within the Fragrance space”
Croda snaps up Spanish fragrances firm Iberchem for £736mln
Croda also noted trading in the half-year to the end of October was in line with expectations
Croda resumes its descent as Barclays cuts its rating to 'underweight' from 'equal-weight'
Croda shares jumped on Tuesday on the back of an agreement with Pfizer to supply excipients, which are substances than improve the efficacy and delivery of the active pharmaceutical ingredients in a drug, to manufacture the US pharma compan